Clinical Trial Update: 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the safety and potential efficacy of 2-Hydroxybenzylamine (2-HOBA) in early Alzheimer's disease. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• 2-Hydroxybenzylamine (2-Hydroxybenzylamine)

Snippet

Sponsor: MTI Biotech Inc | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING